YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations
R Cunningham, S Jia, K Purohit… - Clinical and …, 2023 - Wiley Online Library
The Hippo signalling pathway is dysregulated across a wide range of cancer types and,
although driver mutations that directly affect the core Hippo components are rare, a handful …
although driver mutations that directly affect the core Hippo components are rare, a handful …
Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
A Baird, A Nasser, P Tanuseputro, C Webber… - Current …, 2024 - mdpi.com
Malignant pleural mesothelioma is a rare, aggressive, and incurable cancer with a poor
prognosis and high symptom burden. For these patients, little is known about the impact of …
prognosis and high symptom burden. For these patients, little is known about the impact of …